
Title:
Antihistamine
Text:
Drug that binds to but does not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists


This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details.  (September 2010) (Learn how and when to remove this template message)
.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}AntihistamineDrug classHistamine structureClass identifiersPronunciation/ˌæntiˈhɪstəmiːn/ ATC codeR06Mechanism of action • Receptor antagonist • Inverse agonistBiological targetHistamine receptors • HRH1 • HRH2 • HRH3 • HRH4External linksMeSHD006633In Wikidata
Antihistamines are drugs which treat allergic rhinitis, common cold, influenza, and other allergies.[1]  Typically, people take antihistamines as an inexpensive, not patented (generic), drug that can be bought without a prescription and relieves from nasal congestion, sneezing, or hives caused by pollen, dust mites, or animal allergy with few side effects.[1] Antihistamines are usually for short-term treatment.[1] Chronic allergies increase the risk of health problems which antihistamines might not treat, including asthma, sinusitis, and lower respiratory tract infection.[1] Consultation of a medical professional is recommended for those who intend to take antihistamines for longer-term use.[1]
Although people typically use the word “antihistamine” to describe drugs for treating allergies, doctors and scientists use the term to describe a class of drug that opposes the activity of histamine receptors in the body.[2] In this sense of the word, antihistamines are subclassified according to the histamine receptor that they act upon. The two largest classes of antihistamines are H1-antihistamines and H2-antihistamines.
H1-antihistamines work by binding to histamine H1 receptors in mast cells, smooth muscle, and endothelium in the body as well as in the tuberomammillary nucleus in the brain. Antihistamines that target the histamine H1-receptor are used to treat allergic reactions in the nose (e.g., itching, runny nose, and sneezing). In addition, they may be used to treat insomnia, motion sickness, or vertigo caused by problems with the inner ear. H2-antihistamines bind to histamine H2 receptors in the upper gastrointestinal tract, primarily in the stomach. Antihistamines that target the histamine H2-receptor are used to treat gastric acid conditions (e.g., peptic ulcers and acid reflux).
Histamine receptors exhibit constitutive activity, so antihistamines can function as either a neutral receptor antagonist or an inverse agonist at histamine receptors.[2][3][4][5] Only a few currently marketed H1-antihistamines are known to function as inverse agonists.[2][5]

Contents

1 Medical uses
2 Types

2.1 H1-antihistamines

2.1.1 H1 antagonists/inverse agonists


2.2 H2-antihistamines
2.3 H3-antihistamines
2.4 H4-antihistamines


3 Atypical antihistamines

3.1 Histidine decarboxylase inhibitors
3.2 Mast cell stabilizers


4 History
5 Society and culture
6 Research
7 Special populations
8 See also
9 References
10 External links



Medical uses[edit]
Histamine makes blood vessels more permeable (vascular permeability), causing fluid to escape from capillaries into tissues, which leads to the classic symptoms of an allergic reaction — a runny nose and watery eyes.  Histamine also promotes angiogenesis.[6]
Antihistamines suppress the histamine-induced wheal response (swelling) and flare response (vasodilation) by blocking the binding of histamine to its receptors or reducing histamine receptor activity on nerves, vascular smooth muscle, glandular cells, endothelium, and mast cells.
Itching, sneezing, and inflammatory responses are suppressed by antihistamines that act on H1-receptors.[2][7] In 2014, antihistamines such as desloratadine were found to be effective to complement standardized treatment of acne due to their anti-inflammatory properties and their ability to suppress sebum production.[8][9]

Types[edit]
H1-antihistamines[edit]
.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}Main article: H1-antihistamine
H1-antihistamines refer to compounds that inhibit the activity of the H1 receptor.[4][5] Since the H1 receptor exhibits constitutive activity, H1-antihistamines can be either neutral receptor antagonists or inverse agonists.[4][5]  Normally, histamine binds to the H1 receptor and heightens the receptor's activity; the receptor antagonists work by binding to the receptor and blocking the activation of the receptor by histamine; by comparison, the inverse agonists bind to the receptor and both block the binding of histamine, and reduce its constitutive activity, an effect which is opposite to histamine's.[4] Most antihistamines are inverse agonists at the H1 receptor, but it was previously thought that they were antagonists.[10]
Clinically, H1-antihistamines are used to treat allergic reactions and mast cell-related disorders. Sedation is a common side effect of H1-antihistamines that readily cross the blood–brain barrier; some of these drugs, such as diphenhydramine and doxylamine, may therefore be used to treat insomnia. H1-antihistamines can also reduce inflammation, since the expression of NF-κB, the transcription factor the regulates inflammatory processes, is promoted by both the receptor's constitutive activity and agonist (i.e., histamine) binding at the H1 receptor.[2]
A combination of these effects, and in some cases metabolic ones as well, lead to most first-generation antihistamines having analgesic-sparing (potentiating) effects on opioid analgesics and to some extent with non-opioid ones as well.  The most common antihistamines utilized for this purpose include hydroxyzine, promethazine (enzyme induction especially helps with codeine and similar prodrug opioids), phenyltoloxamine, orphenadrine, and tripelennamine; some may also have intrinsic analgesic properties of their own, orphenadrine being an example.
Second-generation antihistamines cross the blood–brain barrier to a much lesser extent than the first-generation antihistamines. They minimize sedatory effects due to their focused effect on peripheral histamine receptors. However, upon high doses second-generation antihistamines will begin to act on the central nervous system and thus can induce drowsiness when ingested in higher quantity. Additionally, some second-generation antihistamines, notably cetirizine, can interact with CNS psychoactive drugs such as bupropion and benzodiazepines.[11]

H1 antagonists/inverse agonists[edit]
Acrivastine
Alimemazine (a phenothiazine used as antipruritic, antiemetic and sedative)
Amitriptyline (tricyclic antidepressant)
Amoxapine (tetracyclic antidepressant)
Azelastine
Bilastine
Bromodiphenhydramine
Brompheniramine
Buclizine
Carbinoxamine
Cetirizine (Zyrtec)
Chlorodiphenhydramine
Chlorpheniramine
Chlorpromazine (low-potency typical antipsychotic, also used as an antiemetic)
Chlorprothixene (low-potency typical antipsychotic, trade name: Truxal)
Chloropyramine (first generation antihistamine marketed in Eastern Europe)
Cinnarizine (also used for motion sickness and vertigo)
Clemastine
Clomipramine (tricyclic antidepressant)
Clozapine (atypical antipsychotic; trade name: Clozaril)
Cyclizine
Cyproheptadine
Desloratadine
Dexbrompheniramine
Dexchlorpheniramine
Dimenhydrinate (used as an antiemetic and for motion sickness)
Dimetindene
Diphenhydramine (Benadryl)
Dosulepin (tricyclic antidepressant)
Doxepin (tricyclic antidepressant)
Doxylamine (most commonly used as an over-the-counter drug sedative)
Ebastine
Embramine
Fexofenadine (Allegra/Telfast)
Hydroxyzine (also used as an anxiolytic and for motion sickness; trade names: Atarax, Vistaril)
Imipramine (tricyclic antidepressant)
Levocabastine (Livostin/Livocab)
Levocetirizine (Xyzal)
Levomepromazine (low-potency typical antipsychotic)
Loratadine (Claritin)
Maprotiline (tetracyclic antidepressant)
Meclizine (most commonly used as an antiemetic)
Mianserin (tetracyclic antidepressant)
Mirtazapine (tetracyclic antidepressant, also has antiemetic and appetite-stimulating effects; trade name: Remeron)
Olanzapine (atypical antipsychotic; trade name: Zyprexa)
Olopatadine (used locally)
Orphenadrine (a close relative of diphenhydramine used mainly as a skeletal muscle relaxant and anti-Parkinsons agent)
Periciazine (low-potency typical antipsychotic)
Phenindamine
Pheniramine
Phenyltoloxamine
Promethazine (Phenergan)
Pyrilamine (crosses the blood–brain barrier; produces drowsiness)
Quetiapine (atypical antipsychotic; trade name: Seroquel)
Rupatadine (Alergoliber)
Trazodone (SARI antidepressant/anxiolytic/hypnotic with mild H1 blockade action)
Tripelennamine
Triprolidine
H2-antihistamines[edit]
Main article: H2-antihistamine
H2-antihistamines, like H1-antihistamines, exist as inverse agonists and neutral antagonists. They act on H2 histamine receptors found mainly in the parietal cells of the gastric mucosa, which are part of the endogenous signaling pathway for gastric acid secretion. Normally, histamine acts on H2 to stimulate acid secretion; drugs that inhibit H2 signaling thus reduce the secretion of gastric acid.
H2-antihistamines are among first-line therapy to treat gastrointestinal conditions including peptic ulcers and gastroesophageal reflux disease.  Some formulations are available over the counter. Most side effects are due to cross-reactivity with unintended receptors. Cimetidine, for example, is notorious for antagonizing androgenic testosterone and DHT receptors at high doses.
Examples include:

Cimetidine
Famotidine
Lafutidine
Nizatidine
Ranitidine
Roxatidine
Tiotidine
H3-antihistamines[edit]
Main article: H3-antihistamine
An H3-antihistamine is a classification of drugs used to inhibit the action of histamine at the H3 receptor. H3 receptors are primarily found in the brain and are inhibitory autoreceptors located on histaminergic nerve terminals, which modulate the release of histamine. Histamine release in the brain triggers secondary release of excitatory neurotransmitters such as glutamate and acetylcholine via stimulation of H1 receptors in the cerebral cortex. Consequently, unlike the H1-antihistamines which are sedating, H3-antihistamines have stimulant and cognition-modulating effects.
Examples of selective H3-antihistamines include:

Clobenpropit[12]
ABT-239[13]
Ciproxifan[14]
Conessine
A-349,821.[15]
Thioperamide
H4-antihistamines[edit]
H4-antihistamines inhibit the activity of the H4 receptor.
Examples:

Thioperamide
JNJ 7777120
VUF-6002
Atypical antihistamines[edit]
Histidine decarboxylase inhibitors[edit]
Inhibit the action of histidine decarboxylase:

Tritoqualine
Catechin
Mast cell stabilizers[edit]
Main article: Mast cell stabilizer
Mast cell stabilizers are drugs which prevent mast cell degranulation.

cromolyn sodium
Nedocromil
β-agonists
History[edit]
The first H1 receptor antagonists were discovered in the 1930s and these drugs were marketed in the 1940s.[16] Piperoxan was discovered in 1933 and was the first compound with antihistamine effects to be identified.[16] However, piperoxan and its analogues were too toxic to be used in humans.[16] Phenbenzamine (Antergan) was the first clinically useful antihistamine and was introduced for medical use in 1942.[16] Subsequently, many other antihistamines were developed and marketed.[16] Diphenhydramine (Benadryl) was synthesized in 1943, tripelennamine (Pyribenzamine) was patented in 1946, and promethazine (Phenergan) was synthesized in 1947 and launched in 1949.[16][17][18] By 1950, at least 20 different antihistamines had been marketed.[19] Chlorphenamine (Piriton), a less sedating antihistamine, was synthesized in 1951, and hydroxyzine (Atarax, Vistaril), an antihistamine used specifically as a sedative and tranquilizer, was developed in 1956.[16][20] The first non-sedating antihistamine was terfenadine (Seldane) and was developed in 1973.[16][21] Subsequently, other non-sedating antihistamines like loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) were developed and introduced.[16]
The introduction of the first-generation antihistamines marked the beginning of medical treatment of nasal allergies.[22] Research into these drugs led to the discovery that they were H1 receptor antagonists and also to the development of H2 receptor antagonists, where H1-antihistamines affected the nose and the H2-antihistamines affected the stomach.[23] This history has led to contemporary research into drugs which are H3 receptor antagonists and which affect the H4 receptor antagonists.[23] Currently most people who use an H1 receptor antagonist to treat allergies use a second- or third-generation drug.[1]

Society and culture[edit]
The United States government removed two second generation antihistamines, terfenadine and astemizole, from the market based on evidence that they could cause heart problems.[1]

Research[edit]
Not much published research exists which compares the efficacy and safety of the various antihistamines available.[1] The research which does exist is mostly short-term studies or studies which look at too few people to make general assumptions.[1] Another gap in the research is in information reporting the health effects for individuals with long-term allergies who take antihistamines for a long period of time.[1] Newer antihistamines have been demonstrated to be effective in treating hives.[1] However, there is no research comparing the relative efficacy of these drugs.[1]

Special populations[edit]
In 2020, the UK National Health Service wrote that "[m]ost people can safely take antihistamines" but that "[s]ome antihistamines may not be suitable" for young children, the pregnant or breastfeeding, for those taking other medicines, or people with conditions "such as heart disease, liver disease, kidney disease or epilepsy".[24]
Most studies of antihistamines reported on people who are younger, so the effects on people over age 65 are not as well understood.[1] Older people are more likely to experience drowsiness from antihistamine use than younger people.[1] Also, most of the research has been on whites and other races are not as represented in the research.[1] The evidence does not report how antihistamines affect women differently than men.[1] Different studies have reported on antihistamine use in children, with various studies finding evidence that certain antihistamines could be used by children 2 years of age, and other drugs being safer for younger or older children.[1]

See also[edit]
Antileukotriene
Immunotherapy
References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ Jump up to: a b c d e f g h i j k l m n o p q .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Consumer Reports (2013), Using Antihistamines to Treat Allergies, Hay Fever, & Hives - Comparing Effectiveness, Safety, and Price (PDF), Yonkers, New York: Consumer Reports, archived from the original (PDF) on 17 May 2017, retrieved 29 June 2017

^ Jump up to: a b c d e Canonica GW, Blaiss M (2011). "Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence". World Allergy Organ J. 4 (2): 47–53. doi:10.1097/WOX.0b013e3182093e19. PMC 3500039. PMID 23268457. The H1-receptor is a transmembrane protein belonging to the G-protein coupled receptor family. Signal transduction from the extracellular to the intracellular environment occurs as the GCPR becomes activated after binding of a specific ligand or agonist. A subunit of the G-protein subsequently dissociates and affects intracellular messaging including downstream signaling accomplished through various intermediaries such as cyclic AMP, cyclic GMP, calcium, and nuclear factor kappa B (NF-κB), a ubiquitous transcription factor thought to play an important role in immune-cell chemotaxis, proinflammatory cytokine production, expression of cell adhesion molecules, and other allergic and inflammatory conditions.1,8,12,30–32 ... For example, the H1-receptor promotes NF-κB in both a constitutive and agonist-dependent manner and all clinically available H1-antihistamines inhibit constitutive H1-receptor-mediated NF-κB production ... Importantly, because antihistamines can theoretically behave as inverse agonists or neutral antagonists, they are more properly described as H1-antihistamines rather than H1-receptor antagonists.15

^ Panula P, Chazot PL, Cowart M,  et al. (2015). "International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors". Pharmacol. Rev. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.

^ Jump up to: a b c d Leurs R, Church MK, Taglialatela M (April 2002). "H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects". Clinical and Experimental Allergy. 32 (4): 489–98. doi:10.1046/j.0954-7894.2002.01314.x. PMID 11972592. S2CID 11849647.

^ Jump up to: a b c d "H1 receptor". IUPHAR/BPS Guide to Pharmacology. Retrieved 8 October 2015.

^ Norrby K (1995). "Evidence of a dual role of endogenous histamine in angiogenesis". Int J Exp Pathol. 76 (2): 87–92. PMC 1997159. PMID 7540412.

^ Monroe EW, Daly AF, Shalhoub RF (February 1997). "Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines". The Journal of Allergy and Clinical Immunology. 99 (2): S798–806. doi:10.1016/s0091-6749(97)70128-3. PMID 9042073.

^ Lee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, Im M (2014). "Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study". J Eur Acad Dermatol Venereol. 28 (12): 1654–60. doi:10.1111/jdv.12403. PMID 25081735. S2CID 3406128.

^ Layton AM (2016). "Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris". Dermatol Clin. 34 (2): 147–57. doi:10.1016/j.det.2015.11.008. PMID 27015774.

^ Church, Diana S; Church, Martin K (15 March 2011). "Pharmacology of Antihistamines". The World Allergy Organization Journal. 4 (Suppl 3): S22–S27. doi:10.1097/1939-4551-4-S3-S22. ISSN 1939-4551. PMC 3666185. PMID 23282332.

^ "Drug Interaction Report". drugs.com. Retrieved 28 January 2017.

^ Yoneyama H,  et al. (March 2008). "Efficient approaches to S-alkyl-N-alkylisothioureas: syntheses of histamine H3 antagonist clobenpropit and its analogues". The Journal of Organic Chemistry. 73 (6): 2096–104. doi:10.1021/jo702181x. PMID 18278935.

^ Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (April 2005). "Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist". The Journal of Pharmacology and Experimental Therapeutics. 313 (1): 176–90. doi:10.1124/jpet.104.078402. PMID 15608077. S2CID 15430117.

^ Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J (November 1998). "Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist". The Journal of Pharmacology and Experimental Therapeutics. 287 (2): 658–66. PMID 9808693.

^ Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA (September 2004). "Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist". Biochemical Pharmacology. 68 (5): 933–45. doi:10.1016/j.bcp.2004.05.048. PMID 15294456.

^ Jump up to: a b c d e f g h i Ralph Landau; Basil Achilladelis; Alexander Scriabine (1999). Pharmaceutical Innovation: Revolutionizing Human Health. Chemical Heritage Foundation. pp. 230–. ISBN 978-0-941901-21-5.

^ David Healy (July 2009). The Creation of Psychopharmacology. Harvard University Press. pp. 77–. ISBN 978-0-674-03845-5.

^ János Fischer; C. Robin Ganellin (24 August 2010). Analogue-based Drug Discovery II. John Wiley & Sons. pp. 36–. ISBN 978-3-527-63212-1.

^ Moncrieff, Joanna (2013). "Chlorpromazine: The First Wonder Drug". The Bitterest Pills. Palgrave Macmillan UK. pp. 20–38. doi:10.1057/9781137277442_2.

^ Atta-ur-Rahman (11 July 2018). Frontiers in Clinical Drug Research - Anti-Allergy Agents. Bentham Science Publishers. pp. 31–. ISBN 978-1-68108-337-7.

^ Walter Sneader (31 October 2005). Drug Discovery: A History. John Wiley & Sons. pp. 406–. ISBN 978-0-470-01552-0.

^ Ostrom, NK (2014). "The history and progression of treatments for allergic rhinitis". Allergy and Asthma Proceedings. 35 Suppl 1 (3): S3–10. doi:10.2500/aap.2014.35.3758. PMID 25582156.

^ Jump up to: a b Jones, AW (January 2016). "Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H1 and H2 Antagonists". Clinical Pharmacology in Drug Development. 5 (1): 5–12. doi:10.1002/cpdd.236. PMID 27119574. S2CID 29402462.

^ "Antihistamines". NHS. 28 February 2020. Retrieved 28 April 2021.{{cite web}}:  CS1 maint: url-status (link)


External links[edit]
Histamine+antagonist at the US National Library of Medicine Medical Subject Headings (MeSH)
Antihistamine information at Allergy UK
.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteAntihistamines (R06)Benzimidazoles (*)
Astemizole
Azelastine
Bilastine
Emedastine
Mizolastine
Talastine
Diarylmethanes
Diarylmethoxyalkylamines: Bromazine (bromodiphenhydramine)
Carbinoxamine
Chlorphenoxamine
Clemastine
Diphenhydramine (+naproxen)
Diphenylpyraline
Doxylamine
Ebastine
Orphenadrine
Diphenylmethanolpiperidines: Fexofenadine
Terfenadine
Diphenylmethylpiperazines: Buclizine
Cetirizine
Levocetirizine
Chlorcyclizine
Cinnarizine
Cyclizine
Etodroxizine
Hydroxyzine
Meclizine
Oxatomide
Phenylpyridinylpropanamines: Brompheniramine
Chlorphenamine
Dexbrompheniramine (+pseudoephedrine)
Dexchlorpheniramine (+betamethasone)
Pheniramine
Others: Acrivastine
Bamipine
Dimetindene
Phenyltoloxamine
Pyrrobutamine
Quifenadine
Triprolidine
Ethylenediamines
Antazoline
Chloropyramine
Histapyrrodine
Mepyramine (pyrilamine)
Methapyrilene
Phenbenzamine
Thenalidine
Tripelennamine (pyribenzamine)
Tricyclics
Dibenzocycloheptenes: Antidepressants (e.g., amitriptyline)
Azatadine
Cyproheptadine
Deptropine
Desloratadine
Ketotifen
Loratadine
Rupatadine
Phenothiazines: Alimemazine
Fenethazine
Hydroxyethylpromethazine
Isothipendyl
Mequitazine
Methdilazine
Oxomemazine
Promethazine
Others: Antidepressants (e.g., doxepin, mirtazapine, trimipramine)
Epinastine
Latrepirdine
Mebhydrolin
Olopatadine
Perlapine
Phenindamine
Pimethixene
Others
Phenylpiperazines: Antidepressants (e.g., trazodone)
Phenbenzamine
For topical use
Bamipine
Chloropyramine
Chlorphenoxamine
Clemastine
Dimetindene
Diphenhydramine
Doxepin
Isothipendyl
Mepyramine (pyrilamine)
Promethazine

vteHistamine receptor modulatorsH1Agonists
2-Pyridylethylamine
Betahistine
Histamine
HTMT
L-Histidine
UR-AK49
Antagonists
First-generation: 4-Methyldiphenhydramine
Alimemazine
Antazoline
Azatadine
Bamipine
Benzatropine (benztropine)
Bepotastine
Bromazine
Brompheniramine
Buclizine
Captodiame
Carbinoxamine
Chlorcyclizine
Chloropyramine
Chlorothen
Chlorphenamine
Chlorphenoxamine
Cinnarizine
Clemastine
Clobenzepam
Clocinizine
Cloperastine
Cyclizine
Cyproheptadine
Dacemazine
Decloxizine
Deptropine
Dexbrompheniramine
Dexchlorpheniramine
Dimenhydrinate
Dimetindene
Diphenhydramine
Diphenylpyraline
Doxylamine
Embramine
Etodroxizine
Etybenzatropine (ethylbenztropine)
Etymemazine
Fenethazine
Flunarizine
Histapyrrodine
Homochlorcyclizine
Hydroxyethylpromethazine
Hydroxyzine
Isopromethazine
Isothipendyl
Meclozine
Medrylamine
Mepyramine (pyrilamine)
Mequitazine
Methafurylene
Methapyrilene
Methdilazine
Moxastine
Orphenadrine
Oxatomide
Oxomemazine
Perlapine
Phenindamine
Pheniramine
Phenyltoloxamine
Pimethixene
Piperoxan
Pipoxizine
Promethazine
Propiomazine
Pyrrobutamine
Talastine
Thenalidine
Thenyldiamine
Thiazinamium
Thonzylamine
Tolpropamine
Tripelennamine
Triprolidine
Second/third-generation: Acrivastine
Alinastine
Astemizole
Azelastine
Bamirastine
Barmastine
Bepiastine
Bepotastine
Bilastine
Cabastinen
Carebastine
Cetirizine
Clemastine
Clemizole
Clobenztropine
Desloratadine
Dorastine
Ebastine
Efletirizine
Emedastine
Epinastine
Fexofenadine
Flezelastine
Ketotifen
Latrepirdine
Levocabastine
Levocetirizine
Linetastine
Loratadine
Mapinastine
Mebhydrolin
Mizolastine
Moxastine
Noberastine
Octastine
Olopatadine
Perastine
Pibaxizine
Piclopastine
Quifenadine (phencarol)
Rocastine
Rupatadine
Setastine
Sequifenadine (bicarphen)
Talastine
Temelastine
Terfenadine
Vapitadine
Zepastine
Others: Atypical antipsychotics (e.g., aripiprazole, asenapine, brexpiprazole, brilaroxazine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone, zotepine)
Phenylpiperazine antidepressants (e.g., hydroxynefazodone, nefazodone, trazodone, triazoledione)
Tetracyclic antidepressants (e.g., amoxapine, loxapine, maprotiline, mianserin, mirtazapine, oxaprotiline)
Tricyclic antidepressants (e.g., amitriptyline, butriptyline, clomipramine, desipramine, dosulepin (dothiepin), doxepin, imipramine, iprindole, lofepramine, nortriptyline, protriptyline, trimipramine)
Typical antipsychotics (e.g., chlorpromazine, flupenthixol, fluphenazine, loxapine, perphenazine, prochlorperazine, thioridazine, thiothixene)
Unknown/unsorted: Azanator
Belarizine
Elbanizine
Flotrenizine
GSK1004723
Napactadine
Tagorizine
Trelnarizine
Trenizine
H2Agonists
Amthamine
Betazole
Dimaprit
Histamine
HTMT
Impromidine
L-Histidine
UR-AK49
Antagonists
Bisfentidine
Burimamide
Cimetidine
Dalcotidine
Donetidine
Ebrotidine
Etintidine
Famotidine
Isolamtidine
Lafutidine
Lamtidine
Lavoltidine (loxtidine)
Lupitidine
Metiamide
Mifentidine
Niperotidine
Nizatidine
Osutidine
Oxmetidine
Pibutidine
Quisultazine (quisultidine)
Ramixotidine
Ranitidine
Roxatidine
Sufotidine
Tiotidine
Tuvatidine
Venritidine
Xaltidine
Zolantidine
H3Agonists
α-Methylhistamine
Cipralisant
Histamine
Imetit
Immepip
Immethridine
L-Histidine
Methimepip
Proxyfan
Antagonists
A-349821
A-423579
ABT-239
ABT-652
AZD5213
Bavisant
Betahistine
Burimamide
Ciproxifan
Clobenpropit
Conessine
Enerisant
GSK-189254
Impentamine
Iodophenpropit
Irdabisant
JNJ-5207852
NNC 38-1049
PF-03654746
Pitolisant
SCH-79687
Thioperamide
VUF-5681
H4Agonists
4-Methylhistamine
α-Methylhistamine
Histamine
L-Histidine
OUP-16
VUF-8430
Antagonists
JNJ-7777120
Mianserin
Seliforant
Thioperamide
Toreforant
VUF-6002
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors
vtePharmacomodulationTypes
♦ Enzyme: Inducer
Inhibitor
♦ Ion channel: Opener
Blocker
♦ Receptor: Agonist
Partial agonist
Antagonist
Inverse agonist
Positive allosteric modulator (PAM)
Negative allosteric modulator (NAM)
♦ Transporter [Reuptake vs Efflux]: Enhancer (RE)
Inhibitor (RI)
Releaser (RA)
♦ Miscellaneous: Precursor
Cofactor
ClassesEnzymesee Enzyme inhibitionIon channelSee Ion channel modulatorsReceptor &transporterBA/MAdrenergic
Adrenergic receptor agonist (α
β (1
2))
Adrenergic receptor antagonist (α (1
2)
β)
Norepinephrine reuptake inhibitor (NRI)
Dopaminergic
Dopamine receptor agonist
Dopamine receptor antagonist
Dopamine reuptake inhibitor (DRI)
Histaminergic
Histamine receptor agonist
Histamine receptor antagonist (H1
H2
H3)
Serotonergic
Serotonin receptor agonist
Serotonin receptor antagonist (5-HT3)
Serotonin reuptake inhibitor (SRI)
AAGABAergic
GABA receptor agonist
GABA receptor antagonist
GABA reuptake inhibitor (GRI)
Glutamatergic
Glutamate receptor agonist (AMPA)
Glutamate receptor antagonist (NMDA)
Glutamate reuptake inhibitor
Cholinergic
Acetylcholine receptor agonist (Muscarinic
Nicotinic)
Cholinesterase inhibitor
Acetylcholine receptor antagonist (Muscarinic
Nicotinic (Ganglionic
Muscular))
Cannabinoidergic
Cannabinoid receptor agonist
Cannabinoid receptor antagonist
Endocannabinoid enhancer (eCBE)
Endocannabinoid reuptake inhibitor (eCBRI)
Opioidergic
Opioid modulator
Opioid receptor agonist
Opioid receptor antagonist
Enkephalinase inhibitor
Other
Adenosine reuptake inhibitor (AdoRI)
Angiotensin II receptor antagonist
Endothelin receptor antagonist
NK1 receptor antagonist
Vasopressin receptor antagonist
Miscellaneous
Cofactor (see Enzyme cofactors)
Precursor (see Amino acids)






